Search Results - "Doz F"

971P Efficacy and safety of larotrectinib in patients with TRK fusion cancer who had a long-term response.

Authors: Hong, D.S. Doz, F. Xu, R-H. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS635-S636. 2p.

664MO Long-term efficacy and safety of larotrectinib in TRK fusion primary central nervous system tumours: An updated analysis.

Authors: Valero-Arrese, L. Doz, F. Nysom, K. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS484-S485. 2p.

Pharmacologie en oncologie pédiatrique: particularités.

Alternate Title: Paediatric oncology and pharmacology.

Authors: André, N. Doz, F. Leblond, P.

Source: Oncologie (Tech Science Press). Nov2007, Vol. 9 Issue 11, p778-782. 5p.

Phase I trial and pharmacological study of a 3-hour paclitaxel infusion in children with refractory solid tumours: a SFOP study.

Authors: Doz, F Gentet, J C Pein, F et al.

Source: British Journal of Cancer. 3/1/2001, Vol. 84 Issue 5, p604. 7p.

This result is not displayed to guests.
Login for full access.

Quality--of--life, mood and executive functioning after childhood craniopharyngioma treated with surgery and proton beam therapy.

Authors: Laffond, C. Dellatolas, G. Alapetite, C. et al.

Source: Brain Injury. Mar2012, Vol. 26 Issue 3, p270-281. 12p. 3 Charts, 1 Graph.

Subjects: Academic achievement, Analysis of variance, Brain, Cognition, Cognition disorders, Cognition disorders in children, Statistical correlation, Depression in children, Mental depression, Emotions, Interpersonal relations, Interviewing, Life skills, Longitudinal method, Research methodology, Health outcome assessment, Parents, Psychological tests, Quality of life, Questionnaires, Radiation dosimetry, Research funding, Scale analysis (Psychology), Scales (Weighing instruments), Self-evaluation, Statistics, Data analysis, Activities of daily living, Family relations, Social support, Well-being, Educational attainment, Body mass index, Treatment effectiveness, Retrospective studies, Fetal nerve tissue, Descriptive statistics, Children, Tumors

Geographic Terms: France

L’annonce des risques en cancérologie pédiatrique : consolider l’alliance thérapeutique

Alternate Title: Risk announcement in paediatric cancerology: Strengthen the therapeutic alliance

Authors: Doz, F. Davous, D. Seigneur, É. et al.

Source: Archives de Pédiatrie. Mar2008, Vol. 15 Issue 3, p291-300. 10p.

Prenatal diagnosis of dumbbell neuroblastoma.

Authors: Delahaye, S. Doz, F. Sonigo, P. et al.

Source: Ultrasound in Obstetrics & Gynecology. Jan2008, Vol. 31 Issue 1, p92-95. 4p. 3 Diagrams.

Fin de vie de l'enfant et recherche clinique en cancérologie pédiatrique

Alternate Title: End of life and clinical research in pediatric oncology

Authors: Davous, D. Doz, F. Heard, M.

Source: Archives de Pédiatrie. Mar2007, Vol. 14 Issue 3, p274-278. 5p.

Rétinoblastome : aspects récents

Alternate Title: Retinoblatoma: a review

Authors: Doz, F.^1,2 francois.doz@curie.net

Source: Archives de Pédiatrie. Oct2006, Vol. 13 Issue 10, p1329-1337. 9p.

Parental consent in paediatric clinical trials.

Authors: Chappuy J Doz F Blanche S et al.

Source: Archives of Disease in Childhood. Feb2006, Vol. 91 Issue 2, p112-116. 5p.

Parental consent in paediatric clinical research.

Authors: Chappuy, H. Doz, F. Blanche, S. et al.

Source: Archives of Disease in Childhood. Feb2006, Vol. 91 Issue 2, p112-116. 5p. 2 Graphs.

European collaboration in trials of new agents for children with cancer

Authors: Ablett, S. Doz, F. Morland, B. et al.

Source: European Journal of Cancer. Aug2004, Vol. 40 Issue 12, p1886-1892. 7p.

Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy

Authors: Rubie, H. Doz, F. Vassal, G. et al.

Source: European Journal of Cancer. Jul2003, Vol. 39 Issue 10, p1433. 6p.

Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Socie´te´ Franc¸aise d'Oncologie Pe´diatrique

Authors: Doz, F. Neuenschwander, S. Bouffet, E. et al.

Source: European Journal of Cancer. Apr2002, Vol. 38 Issue 6, p815. 5p.

Effets indésirables de la chimiothérapie anticancéreuse

Alternate Title: Late effects of cancer chemotherapy in children

Authors: Doz, F.¹ francois.doz@curie.net

Source: Archives de Pédiatrie. Jun2007, Vol. 14 Issue 6, p612-614. 3p.

Le réseau hospitalier spécialisé en cancérologie pédiatrique

Alternate Title: Hospital network in pediatric oncology

Authors: Doz, F.¹

Source: Archives de Pédiatrie. Jun2006, Vol. 13 Issue 6, p635-637. 3p.

366PActivity of larotrectinib in TRK fusion cancer patients with primary central nervous system tumours.

Authors: Ziegler, D S Doz, F Geoerger, B et al.

Source: Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p.

Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study.

Authors: Brasme JF Chalumeau M Doz F et al.

Source: European Journal of Pediatrics. Jan2012, Vol. 171 Issue 1, p25-32. 8p.

Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma.

Authors: Sastre X Chantada GL Doz F et al.

Source: Archives of Pathology & Laboratory Medicine. Aug2009, Vol. 133 Issue 8, p1199-1202. 4p.

URL: 43568284